Condensed Consolidating Financial Statements - Additional Information (Details) |
Sep. 08, 2020
USD ($)
Debtinstrument
|
Jan. 21, 2020
USD ($)
Debtinstrument
|
---|---|---|
Iterum Therapeutics Bermuda Limited | ||
Condensed Financial Statements Captions [Line Items] | ||
Ownership percentage | 100.00% | |
Subsidiary Guarantors | ||
Condensed Financial Statements Captions [Line Items] | ||
Ownership percentage | 100.00% | |
Private Placement | 2025 Exchangeable Notes | ||
Condensed Financial Statements Captions [Line Items] | ||
Aggregate principal amount | $ 51,588,000 | |
Debt instrument price per unit | 1,000 | |
Private Placement | RLNs | ||
Condensed Financial Statements Captions [Line Items] | ||
Aggregate principal amount | $ 103,000 | |
Number of debt instruments within each notes | Debtinstrument | 50 | 50 |
Rights Offering | 2025 Exchangeable Notes | ||
Condensed Financial Statements Captions [Line Items] | ||
Aggregate principal amount | $ 220,000 | |
Rights Offering | RLNs | ||
Condensed Financial Statements Captions [Line Items] | ||
Aggregate principal amount | $ 440 |
X | ||||||||||
- Definition Number of debt instruments within each unit. No definition available.
|
X | ||||||||||
- Definition Unit price per debt instrument. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|